Hello, this is Ryuta Hamamoto from TIMEWELL Inc.
The U.S. public health insurance program Medicaid is a vital system supporting the healthcare of approximately 90 million people — including low-income individuals, people with disabilities, pregnant women, children, and seniors. However, it faces serious challenges: rapidly rising healthcare costs, disparities in healthcare access, and the need to improve quality.
Waymark is a startup taking on these challenges with cutting-edge AI technology and a community-based care model. The company's proprietary machine learning algorithm predicts patient risk with more than 90% accuracy, and early interventions have delivered remarkable results — including a 22.9% reduction in emergency department visits.
This article provides a detailed explanation of Waymark's technology, business model, track record, and the potential for AI to transform healthcare.
Waymark Overview and Background
Company Overview
| Item | Details |
|---|---|
| Legal name | Waymark Health, Inc. (Waymark) |
| Founded | 2021 |
| Headquarters | San Francisco, California |
| Corporate form | Public Benefit Corporation (PBC) |
| Total funding raised | Approximately $87 million |
| Key investors | Andreessen Horowitz (a16z), CVS Health Ventures, Lux Capital, New Enterprise Associates |
| Target area | Community-based care for Medicaid enrollees |
Founders' Backgrounds
Rajaie Batniji — CEO and Co-founder Led healthcare product development at Google for nine years. Convinced that technology can contribute to improving healthcare access and treatment outcomes, he co-founded Waymark.
Sanjay Basu — Co-founder A physician and healthcare policy expert. Having witnessed firsthand the challenges faced by socially disadvantaged populations in daily clinical practice, he co-founded Waymark with the goal of solving those challenges through technology.
Why They Chose the Public Benefit Corporation (PBC) Structure
Waymark was established as a PBC — a form of corporation that is legally required to pursue not only shareholder interests but also the public good. This choice makes clear the company's commitment to prioritizing social impact over short-term profit.
The Technology Behind the Proprietary AI "Waymark Signal"
Waymark's core technology is its proprietary machine learning algorithm, "Waymark Signal."
How Waymark Signal Works
Waymark Signal integrates multiple data sources to predict a patient's "rising risk."
Data sources used:
- Local emergency department (ED) visit data
- Primary care physician visit data
- Prescription drug data
- Social services databases
- Health plan data
- Environmental data (wildfire smoke, temperature fluctuations, etc.)
Prediction Accuracy and Features
| Metric | Waymark Signal |
|---|---|
| Prediction accuracy | Over 90% |
| Comparison with traditional methods | 3x more accurate |
| Prediction target | Avoidable emergency department and inpatient utilization |
| Key feature | Comprehensive risk assessment incorporating social and environmental factors |
Particularly notable is the integration of not just medical data, but also social and environmental factors. For example, by combining wildfire smoke data with a list of asthma patients, it becomes possible to proactively prescribe additional inhalers to those patients before the smoke reaches them.
Looking for AI training and consulting?
Learn about WARP training programs and consulting services in our materials.
Outcomes Demonstrated in Clinical Research
Waymark's results have been demonstrated in clinical research published in the prestigious medical journal NEJM Catalyst Innovations in Care Delivery.
Research Overview
The study was conducted on 64,278 patients enrolled in two Medicaid health plans in Washington State and Virginia, in collaboration with 2,298 primary care providers.
Key Outcome Metrics
| Metric | Improvement |
|---|---|
| All-cause ED and inpatient visits | 22.9% reduction |
| Avoidable ED visits | 20.4% reduction |
| Avoidable inpatient admissions | 48.3% reduction |
| Care quality indicators (7 of 9 metrics) | Average improvement of 11.8 points |
These results come from a six-month comparison between patients who received Waymark's services and a statistically matched control group.
Particularly Notable Result
The 48.3% reduction in avoidable inpatient admissions simultaneously improves patient quality of life and delivers major reductions in healthcare costs. Given that the average cost per hospitalization ranges from thousands to tens of thousands of dollars, the economic impact of this reduction is extremely significant.
Community-Based Care Model
Waymark's defining characteristic is not relying on AI alone, but adopting a hybrid model that combines AI with local community health workers and care teams.
The Care Flow
- Risk prediction: Waymark Signal predicts risk for Medicaid enrollees
- Patient identification: Identifies patients at high risk of near-term ED utilization
- Notification to local team: Sends alerts to local community health workers
- Early intervention: Home visits or phone calls to check health status
- Primary care coordination: Encourages patients to visit their primary care physician as needed
- Social support provision: Food assistance, housing support, transportation, and more
Human-Centered AI Use
Waymark has explicitly committed to "ethical AI use." AI is positioned not as a replacement for healthcare provider judgment, but as a tool to support more effective intervention. Final medical decisions are always made by human healthcare providers, with AI providing the information that supports those decisions.
Funding and Growth Strategy
Funding History
| Round | Timing | Amount | Key Investors |
|---|---|---|---|
| Seed | 2021 | Undisclosed | Andreessen Horowitz |
| Series A | 2022 | ~$45M | a16z, CVS Health Ventures |
| Series B | Fall 2023 | ~$42M | Lux Capital, NEA, a16z |
Total funding of $87 million is a noteworthy scale for a healthcare AI startup. In particular, the investment from CVS Health Ventures (the investment arm of CVS, the largest pharmacy chain in the U.S.) is testament to the recognition of Waymark's technology's practical utility in real healthcare settings.
Geographic Expansion
The company currently operates primarily in Washington State and Virginia but is expanding to other states. With approximately 90 million Medicaid enrollees in the U.S., this is a market with enormous room for growth.
Implications for Japan's Healthcare System
Waymark's work also offers important insights for healthcare in Japan.
Differences Between Japan and U.S. Healthcare Systems
| Item | Japan (Universal health insurance) | U.S. (Medicaid) |
|---|---|---|
| Coverage | All citizens | Low-income individuals, people with disabilities, etc. |
| Patient cost sharing | Typically 30% | Low to zero |
| Access | Relatively equal | Large regional and economic disparities |
| Preventive care | Health checkup systems in place | Varies by plan |
While Japan's universal health insurance system means disparities in healthcare access are relatively small, challenges such as rising healthcare costs due to an aging population, physician shortages in rural areas, and promoting preventive care are all areas where Waymark's approach can serve as a useful reference.
The Potential of AI-Powered Healthcare
The use of AI to improve healthcare efficiency is advancing in Japan as well. In particular, there are many areas where predictive AI like Waymark's is expected to add value — preventing the progression of lifestyle diseases, and monitoring systems for elderly patients receiving home medical care, among others.
TIMEWELL provides the AI consulting service "WARP" to support AI adoption across a wide range of industries, including healthcare. We strategically support the digital transformation of healthcare organizations and health-related companies, informed by the latest trends in AI technology.
Summary
- Waymark is a PBC (Public Benefit Corporation) founded in 2021, a startup taking on U.S. Medicaid reform through AI and community care
- Proprietary machine learning "Waymark Signal" integrates medical, social, and environmental data to predict patient risk with over 90% accuracy
- Clinical research has demonstrated a 22.9% reduction in ED visits and a 48.3% reduction in avoidable inpatient admissions
- Total of $87 million raised from a16z, CVS Health Ventures, Lux Capital, and others
- AI is positioned as a tool to support healthcare provider judgment — a thoroughly human-centered approach
- In Japan too, predictive AI holds significant potential for addressing the challenges of aging populations and rising healthcare costs
References
- Waymark Official Website
- NEJM Catalyst - Supporting Rising-Risk Medicaid Patients Through Early Intervention
- Waymark Research
- Healthcare Innovation - Waymark Receives $45M to Enhance Medicaid Managed Care
- News-Medical.net - Innovative Approach by Waymark Enhances Health Outcomes
Related Articles
- The Reality of a Working Mother Returning from Two Maternity Leaves — And How Her Work Philosophy Changed | TIMEWELL
- Before Taking Paternity Leave (Part 2): Three Absolute Must-Dos for Taking Leave During a Busy Season
- A First-Class Architect Who Stays Close to the Job Site — Finding My Own Path as the Fifth-Generation Leader of a Construction Company
